Full Name
Dr. Àlex Rovira
Position/Title
Head Neuroradiology
Organization/Company
Hospital Vall d'Hebron
Speaker Bio
Dr Àlex Rovira is a full-time neuroradiologist, who gained his MD in 1983 at the Autonomous University of Barcelona. After formal training in Radiology at Vall d’Hebron University Hospital (Barcelona), he undertook a visiting fellowship at Shands Hospital (Gainesville, University of Florida) in 1989. In 1990, he became a staff neuroradiologist at the Section of Neuroradiology at Vall d’Hebron Hospital (Barcelona, Spain). He is specialized in diagnostic neuroradiology, and head and neck radiology, with a particular interest in demyelinating diseases, stroke, neuro-oncology, and neurodegenerative disorders.
Dr Rovira is the Director of the Section of Neuroradiology at University Hospital Vall d’Hebron, and of the Neuroradiology Research Group at Vall d’Hebron Research Institute (VHIR), Barcelona (Spain).
He is currently chair of Referral Guidelines Subcommittee of the European Society of Radiology and of the ESNR Green Committee, and member of the Steering Committee of MAGNIMS (European Multicenter Collaborative Research Network on MRI in MS). He is on the editorial boards of Neurology, Neuroradiology and Canadian Association of Radiologist Journal.
He is Honorary Lecturer at University College of London, and served as associate Professor of Radiology and Neuroimmunology at the Autonomous University of Barcelona, and as Honorary Associated Professor at University College of London.
He also served as President of the European Society of Neuroradiology (2016-2018), as President of the Spanish Society of Neuroradiology (2009-2015), on the Lucien Appel Prize Award Jury of the European Society of Neuroradiology (2006-2012), as Editor of Neuroradiology in the Spanish Journal of Radiology, as Director of the 10th and 11th Cycles of the European Course of Neuroradiology (2008-2012), as Chairman of MAGNIMS (2012-2018), and member of the Research Committee of the European Society of Radiology, of the Executive Committee of the Spanish Society of Radiology (2014-2022), of the World Federation of Neuroradiological Societies (2018-2022), and of the International Society of Radiology (2020-2023)
Dr Rovira has authored/co-authored more than 580 articles (Scopus; total citations 26.000; h-index: 85), 30 book chapters or monographs, and more than 500 invited conference presentations. He is also the editor of three books: “Essential Radiology” (Panamericana 2019), “Clinical Neuroradiology” (Springer 2019), and “Controversies in Radiology” (Aran 2020). He has been invited as Visiting Professor at the University of Toronto, McGill University (Montreal), Lysholm Department of Neuroradiology (UCL, London), Ottawa University, and University of North Carolina (Chapel Hill).
He is an honorary member of the European Society of Neuroradiology, the Bulgarian Society of Neuroradiology, the Paulista Society of Radiology, and of the Polish Society of Radiology.
Dr Rovira has made relevant contributions on the value of MRI as a biomarker in different neurological disorders, in particular in autoimmune central nervous system disorders.
The speaker discloses the following relationships:
- Receipt of financial payments from Bayer, Sanofi, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers, and Biogen.
- Service on advisory boards or bureaus for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, and Biogen, with payments received personally or on behalf of their institution.
- Recipient of funded grants for research projects PI19/00950 and PI22/01589 from the Fondo de Investigación en Salud at Instituto de Salud Carlos III, Spain.
- Service as Chief Medical Officer (CMO) and co-founder of TensorMedical.
Dr Rovira is the Director of the Section of Neuroradiology at University Hospital Vall d’Hebron, and of the Neuroradiology Research Group at Vall d’Hebron Research Institute (VHIR), Barcelona (Spain).
He is currently chair of Referral Guidelines Subcommittee of the European Society of Radiology and of the ESNR Green Committee, and member of the Steering Committee of MAGNIMS (European Multicenter Collaborative Research Network on MRI in MS). He is on the editorial boards of Neurology, Neuroradiology and Canadian Association of Radiologist Journal.
He is Honorary Lecturer at University College of London, and served as associate Professor of Radiology and Neuroimmunology at the Autonomous University of Barcelona, and as Honorary Associated Professor at University College of London.
He also served as President of the European Society of Neuroradiology (2016-2018), as President of the Spanish Society of Neuroradiology (2009-2015), on the Lucien Appel Prize Award Jury of the European Society of Neuroradiology (2006-2012), as Editor of Neuroradiology in the Spanish Journal of Radiology, as Director of the 10th and 11th Cycles of the European Course of Neuroradiology (2008-2012), as Chairman of MAGNIMS (2012-2018), and member of the Research Committee of the European Society of Radiology, of the Executive Committee of the Spanish Society of Radiology (2014-2022), of the World Federation of Neuroradiological Societies (2018-2022), and of the International Society of Radiology (2020-2023)
Dr Rovira has authored/co-authored more than 580 articles (Scopus; total citations 26.000; h-index: 85), 30 book chapters or monographs, and more than 500 invited conference presentations. He is also the editor of three books: “Essential Radiology” (Panamericana 2019), “Clinical Neuroradiology” (Springer 2019), and “Controversies in Radiology” (Aran 2020). He has been invited as Visiting Professor at the University of Toronto, McGill University (Montreal), Lysholm Department of Neuroradiology (UCL, London), Ottawa University, and University of North Carolina (Chapel Hill).
He is an honorary member of the European Society of Neuroradiology, the Bulgarian Society of Neuroradiology, the Paulista Society of Radiology, and of the Polish Society of Radiology.
Dr Rovira has made relevant contributions on the value of MRI as a biomarker in different neurological disorders, in particular in autoimmune central nervous system disorders.
The speaker discloses the following relationships:
- Receipt of financial payments from Bayer, Sanofi, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers, and Biogen.
- Service on advisory boards or bureaus for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, and Biogen, with payments received personally or on behalf of their institution.
- Recipient of funded grants for research projects PI19/00950 and PI22/01589 from the Fondo de Investigación en Salud at Instituto de Salud Carlos III, Spain.
- Service as Chief Medical Officer (CMO) and co-founder of TensorMedical.
Speaking At
